FR2686512B1 - PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE INGREDIENT COMBINATIONS OF VANADIUM AND / OR NIOBIUM WITH PYROCATECHOL DERIVATIVES. - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE INGREDIENT COMBINATIONS OF VANADIUM AND / OR NIOBIUM WITH PYROCATECHOL DERIVATIVES.

Info

Publication number
FR2686512B1
FR2686512B1 FR9200889A FR9200889A FR2686512B1 FR 2686512 B1 FR2686512 B1 FR 2686512B1 FR 9200889 A FR9200889 A FR 9200889A FR 9200889 A FR9200889 A FR 9200889A FR 2686512 B1 FR2686512 B1 FR 2686512B1
Authority
FR
France
Prior art keywords
niobium
vanadium
active ingredient
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9200889A
Other languages
French (fr)
Other versions
FR2686512A1 (en
Inventor
Maurel Jean-Claude
Kiesgen De Richter Renaud
Rose Eric
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IR2M
Original Assignee
IR2M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IR2M filed Critical IR2M
Priority to FR9200889A priority Critical patent/FR2686512B1/en
Priority to EP93904111A priority patent/EP0624092A1/en
Priority to PCT/FR1993/000068 priority patent/WO1993014751A1/en
Priority to PCT/FR1993/000067 priority patent/WO1993014772A1/en
Publication of FR2686512A1 publication Critical patent/FR2686512A1/en
Application granted granted Critical
Publication of FR2686512B1 publication Critical patent/FR2686512B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9200889A 1992-01-28 1992-01-28 PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE INGREDIENT COMBINATIONS OF VANADIUM AND / OR NIOBIUM WITH PYROCATECHOL DERIVATIVES. Expired - Lifetime FR2686512B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR9200889A FR2686512B1 (en) 1992-01-28 1992-01-28 PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE INGREDIENT COMBINATIONS OF VANADIUM AND / OR NIOBIUM WITH PYROCATECHOL DERIVATIVES.
EP93904111A EP0624092A1 (en) 1992-01-28 1993-01-22 Utilization of niobium derivatives as active principle of medicaments useful in the treatment and/or prevention of glucid and/or lipid metabolium troubles
PCT/FR1993/000068 WO1993014751A1 (en) 1992-01-28 1993-01-22 Pharmaceutical compositions containing as active principle associations of vanadium and/or niobium with pyrocatechol derivatives
PCT/FR1993/000067 WO1993014772A1 (en) 1992-01-28 1993-01-22 Utilization of niobium derivatives as active principle of medicaments useful in the treatment and/or prevention of glucid and/or lipid metabolium troubles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9200889A FR2686512B1 (en) 1992-01-28 1992-01-28 PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE INGREDIENT COMBINATIONS OF VANADIUM AND / OR NIOBIUM WITH PYROCATECHOL DERIVATIVES.

Publications (2)

Publication Number Publication Date
FR2686512A1 FR2686512A1 (en) 1993-07-30
FR2686512B1 true FR2686512B1 (en) 1995-06-30

Family

ID=9426047

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9200889A Expired - Lifetime FR2686512B1 (en) 1992-01-28 1992-01-28 PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE INGREDIENT COMBINATIONS OF VANADIUM AND / OR NIOBIUM WITH PYROCATECHOL DERIVATIVES.

Country Status (2)

Country Link
FR (1) FR2686512B1 (en)
WO (1) WO1993014751A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2729956B1 (en) * 1995-01-31 1997-04-18 Maurel Sante ORGANOMETALLIC COMPLEXES BASED ON SITOSTEROLS AND ACYLGLYCEROLS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2729957B1 (en) * 1995-01-31 1997-12-05 Maurel Sante ORGANOMETALLIC COMPLEXES BASED ON SITOSTEROLS AND ACYLGLYCEROLS AND PHARMACEUTICAL COMPOSITIONS AND DIETETIC PRODUCTS CONTAINING SAME.
FR2750606B1 (en) * 1996-07-03 1999-01-29 Maurel Sante ORGANOMETALLIC COMPLEXES BASED ON SITOSTEROLS AND DIGLYCERIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
WO1999017761A1 (en) * 1997-10-06 1999-04-15 Shaman Pharmaceuticals, Inc. Use of nordihydroguaiaretic acid to lower serum triglycerides, blood pressure and to treat syndrome x
WO2000056302A2 (en) * 1999-03-19 2000-09-28 Parker Hughes Institute Vanadium (iv) complexes containing catacholate ligand and having spermicidal activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1277599C (en) * 1986-10-16 1990-12-11 Barry I. Posner Vanadium - peroxide compositions as insulin mimickers
JPH01501791A (en) * 1986-11-19 1989-06-22 ケメックス　ファーマシューティカルズ，インコーポレイティド Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts

Also Published As

Publication number Publication date
WO1993014751A1 (en) 1993-08-05
FR2686512A1 (en) 1993-07-30

Similar Documents

Publication Publication Date Title
CA2173328A1 (en) HIV Protease Inhibitors
FR2453644B1 (en) STABLE DRUG SOLUTIONS APPLICABLE PARENTALLY, CONTAINING, AS ACTIVE INGREDIENTS, A DERIVATIVE OF ARYLACETIC OR ARYLPROPIONIC ACID WITH PHOSPHOLIPIDS AND THEIR PREPARATION
FR2635265B1 (en) INTRAVENOUS PHARMACEUTICAL COMPOSITION COMPRISING CYCLOSPORIN AS ACTIVE INGREDIENT AND PROCESS FOR THE PREPARATION THEREOF
MX9102209A (en) DERIVATIVES OF NEW HYDROXAMIC ACID AND N-HYDROXYUREA AND ITS USE.
RU92004423A (en) CURCUMA PLANT PRODUCT
ATE63220T1 (en) TRANSDERMALLY ABSORBABLE, AQUEOUS PREPARATIONS OF ARYLPROPIONIC ACID DERIVATIVES AND PROCESS FOR THE MANUFACTURE OF THE SAME.
TNSN97015A1 (en) NEW 19-NOR-PREGNENE DERIVATIVES.
FR2602141B1 (en) PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY CONTAINING IBUPROFENE AS ACTIVE INGREDIENT
HUP0003571A2 (en) 6,9-bridged erythromycin derivatives
GR3035014T3 (en) N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors
DE3583916D1 (en) AQUEOUS MEDICINE FORMULATIONS OF PIROXICAMMONOHYDRATE.
FR2686512B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE INGREDIENT COMBINATIONS OF VANADIUM AND / OR NIOBIUM WITH PYROCATECHOL DERIVATIVES.
FR2598320B1 (en) WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS CONTAINING UBIQUINONE AS ACTIVE INGREDIENT USEFUL IN DIFFERENT THERAPEUTIC APPLICATIONS
KR970032872A (en) Drugs for the treatment of skin damage containing acetylsalicylic acid
FR2490491B1 (en) ANALGESIC PHARMACEUTICAL COMPOSITION CONTAINING AS ACTIVE INGREDIENT 3-AMINO-2-HYDROXY-4 PHENYLBUTANOIC ACID AND DERIVATIVES THEREOF AND APPLICATION
FR2343730A1 (en) DERIVATIVES OF AMIDINOFORMIC ACID OR AMIDINOSULFINIC ACID, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2363324A1 (en) AQUEOUS OR HYDROALCOOLIC STABLE SOLUTIONS OF PERFUMED ESSENCES OR OIL SOLUBLE MEDICINAL PRODUCTS
DE69103773D1 (en) DERIVATIVES OF HYDROXAMIC ACID INHIBIT THE LIPOXYGENASE.
ES2040240T3 (en) PLATINUM CYSTOSTATIC AGENT.
DE69119884D1 (en) DERIVATIVES OF N-ACYL-N-PHENYLTETRAHYDROPHTHALAMIC ACID, THEIR PRODUCTION AND HERBICIDES THAT CONTAIN THEM AS ACTIVE INGREDIENTS
HUP9903892A2 (en) Hydroxamic acid derivatives
FR2686514B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING AS ACTIVE INGREDIENT COMBINATIONS OF VANADIUM AND / OR NIOBIUM WITH ORGANIC COMPOUNDS CONTAINING A CYCLE CONTAINING AT LEAST TWO NITROGEN ATOMS.
ATE100670T1 (en) PLANT FUNGICIDES CONTAINING SALTS OF PYROPHOSPHORIC ACID AS ACTIVE SUBSTANCES AND THEIR APPLICATION.
KR927002996A (en) Hair growth promoting composition
DE69301716D1 (en) 3-azabicyclo (3.1.0) hexan-2-one derivatives, and herbicidal compositions containing these as herbicide active ingredients